Atlas Trials

Effectiveness, Safety and Feasibility of HECT-CL, in Quetta, Pakistan

Clinical trial NCT03208543 · TERMINATED

Trial details

NCT number
NCT03208543
Sponsor
Medecins Sans Frontieres, Netherlands
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Cutaneous Leishmaniases
Start date
2017-10-04
Primary completion
2017-12-20
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.